Back
PT Bank Central Asia Tbk Vs. Avidity Biosciences Industry Stock Comparison
Sell
44
PBCRF
PT Bank Central Asia Tbk
Last Price:
$0.55
Seasonality Move:
1.39%
Sell
34
RNA
Avidity Biosciences
Last Price:
$32.11
Seasonality Move:
-10.33%
Sell
44
PT Bank Central Asia Tbk (PBCRF)
is a Sell
Is PT Bank Central Asia Tbk a Buy, Sell or Hold?
-
The current PT Bank Central Asia Tbk [PBCRF] share price is $0.55. The Score for PBCRF is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
PBCRF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
-
The current Avidity Biosciences [RNA] share price is $32.13. The Score for RNA is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PBCRF Stock Price Chart
What is PT Bank Central Asia Tbk's stock price today?
-
The PT Bank Central Asia Tbk share price today is $0.55The current trend is relatively stagnant and PBCRF is experiencing slight buying pressure.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $32.13The current trend is relatively stagnant and RNA is experiencing selling pressure, which indicates risk of future bearish movement.
PBCRF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 50.28 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.52 - 0.56) | Buy |
Bollinger Bands (100): | (0.54 - 0.66) | Sell |
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.3 | Sell |
Relative Strength Index (14 RSI): | 54.74 | Buy |
Chaikin Money Flow: | -1849074 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.71 - 33.63) | Buy |
Bollinger Bands (100): | (29.46 - 43.3) | Sell |
PBCRF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.53 | Buy |
20-day SMA: | 0.54 | Buy |
50-day SMA: | 0.56 | Sell |
200-day SMA: | 0.62 | Sell |
8-day EMA: | 0.54 | Buy |
20-day EMA: | 0.54 | Buy |
50-day EMA: | 0.56 | Sell |
200-day EMA: | 0.6 | Sell |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.29 | Buy |
20-day SMA: | 30.97 | Buy |
50-day SMA: | 30.96 | Buy |
200-day SMA: | 38.58 | Sell |
8-day EMA: | 30.89 | Buy |
20-day EMA: | 30.96 | Buy |
50-day EMA: | 32.21 | Sell |
200-day EMA: | 34.03 | Sell |
PT Bank Central Asia Tbk Earnings Growth & PBCRF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.99 per share, and a decrease next year of $0.57 per share.
PT Bank Central Asia Tbk Technical Analysis
Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avidity Biosciences Technical Analysis
Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |